AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2020
Feb 27, 2020
35124_dirs_2020-02-27_735a1ecc-4a14-4fdd-91ce-ee142ce99db4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2020-02-25
Reporting Person: Braun Donald P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | Option to Purchase Celsion Corporation Common Stock | $1.16 | A | 6000 | Acquired | 2030-02-25 | Celsion Corporation Common Stock (6000) | Direct |
Footnotes
F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.
More from Imunon, Inc.
Board/Management Information
2026
Jun 30
Call Transcript
2026
Jun 25
Regulatory Filings
2026
Jun 17
Board/Management Information
2026
Jun 16
Call Transcript
2026
Jun 16
Capital/Financing Update
2026
Jun 4
Call Transcript
2026
May 12
Call Transcript
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12